MétaCan
Menu
← Back to cohort

Preliminary results of a phase I study of stereotactic radiotherapy for unresectable primary and metastatic liver cancer

2005· article· en· W2589489743 on OpenAlexaffabout
M. Hawkins, C. Eccles, G. Lockwood, B. Cummings, Jolie Ringash, Jennifer J. Knox, M. Sherman, Paul D. Greig, Steven Gallinger, Laura A. Dawson

Bibliographic record

VenueJournal of Clinical Oncology · 2005
Typearticle
Languageen
FieldMedicine
TopicHepatocellular Carcinoma Treatment and Prognosis
Canadian institutionsMount Sinai Hospital
Fundersnot available
KeywordsMedicineToxicityHepatocellular carcinomaCancerRadiation therapyPrimary tumorPhases of clinical researchNuclear medicineInternal medicineOncologyGastroenterologyRadiologySurgeryMetastasis

Abstract

fetched live from OpenAlex

4127 Purpose: To report initial toxicity and response data from a phase I study of stereotactic radiotherapy (SRT) for unresectable liver cancer. Methods: Eligible patients have unresectable or medically inoperable primary or metastatic liver cancer, Childs score A and KPS ≥ 60. Standard treatment options have been explored. Patients are stratified based on diagnosis (metastases vs. primary cancer) and volume of uninvolved liver treated (< 20%, 20–50%, 50–80%). SRT is delivered in 6 fractions/2 weeks to maximize patient convenience, resource utilization and therapeutic gain. Dose is individualized to maintain the same estimated risk of liver toxicity for patients at each level (level I - 5% risk, level II - 10% risk, level III - 20%, max. dose 60 Gy in 6 fractions). Escalation to level II and III occurs once at least 3 patients have been followed for >3 months without dose limiting toxicity for each stratum at the previous level. Patients are treated during breath hold to reduce organ motion, with daily imaging and repositioning to reduce setup error. Acute toxicity scored using CTC v3.0. Results: From Aug 2003 to Dec 2004, 36 patients completed SRT at levels I and II (14 hepatocellular carcinoma, 6 cholangiocarcinoma, 16 metastases). The median tumor volume was 213.9 cm3 (range 9.2 to 3088cm3). The average SRT dose to tumor was 35.7 Gy (range: 24 to 56.3 Gy). Median follow-up was 5.5 months (1.4 to 14.9 months). No grade 4/5 related toxicity was seen. At 1 month, 4 patients with HCC had a decline in liver function to Child B. No radiation-induced liver disease (RILD) was observed. Toxicity within 3 months included: grade 3 fatigue (1), vomiting (1); grade 2: thrombocytopenia (2), gastritis (4), pruritis (2), vomiting (2), nausea (6), anorexia (2) fatigue (8), hepatic pain (2). One gastrointestinal bleed occurred 6.4 months following SRT in a patient with tumor extension to the stomach on endoscopy. In 28 evaluable patients, in-field response assessed using CT at 3 months was: CR (1), PR (9), MR/SD (14), PD (4) Conclusion: This approach of individualized dose SRT appears safe, with no severe liver toxicity observed to date. More patients and longer follow up are required for a further assessment of late toxicity and efficacy. Author Disclosure Employment or Leadership Consultant or Advisory Role Stock Ownership Honoraria Research Funding Expert Testimony Other Remuneration ASCO CDA, Canadian Institutes of Health Research, NIH (US)/ NCI, NIH (US)/ Ontario portion/year, Ontario Cancer Research Network, Lustgarten Foundation for Pancreatic Cancer Research

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Non-randomized trial · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.003
Threshold uncertainty score0.011

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0020.002
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0020.001
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0010.000
Research integrity0.0010.002
Insufficient payload (model declined to judge)0.0030.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.276
GPT teacher head0.483
Teacher spread0.206 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNon-randomized trial
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations4
Published2005
Admission routes2
Has abstractyes

Explore more

Same venueJournal of Clinical Oncology→Same topicHepatocellular Carcinoma Treatment and Prognosis→French-language works237,207→